← Back to Search

Mindfulness Oriented Recovery Enhancement Sessions for Opioid Use Disorder

N/A
Waitlist Available
Led By Benjamin Bearnot, MD
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

Study Summary

This trial will study the effects of adding a mind-body therapy to the standard of care for people with moderate to severe opioid use disorder.

Eligible Conditions
  • Opioid Use Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Addiction Severity
Enrollment feasibility as measured by the number of individuals who enroll in the study as compared to those who are eligible to enroll
Secondary outcome measures
Completion of 12-week Follow-up Feasibility
Completion of at least 4 MORE sessions feasibility
Distress Tolerance
+2 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Mindfulness Oriented Recovery Enhancement (MORE) ArmExperimental Treatment1 Intervention
During hospitalization, participants will receive brief mindfulness training individually in person and complete a series of quantitative baseline questionnaires. Participants will complete 1 MORE session weekly for 8 sessions delivered in small groups of up to 10 people. These sessions will be delivered by a social worker in-person at baseline, and via telehealth after discharge. Follow-up surveys will be conducted at 3-, 6-. 9-, and 12- weeks, and an audio-recorded qualitative exit interview (45-60 minutes) will be completed upon completion of the intervention and the 12-week follow-up survey.

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
2,929 Previous Clinical Trials
13,198,285 Total Patients Enrolled
Benjamin Bearnot, MDPrincipal InvestigatorMassachusetts General Hospital

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Mindfulness Oriented Recovery Enhancement in Hospitalized People With Opioid Use Disorder
Benjamin Bearnot, M.D. 2022. "Mindfulness Oriented Recovery Enhancement in Hospitalized People With Opioid Use Disorder". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05066321.
~6 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top